Long-term Temozolomide Treatment Induces Marked Amino Metabolism Modifications and an Increase in TMZ Sensitivity in Hs683 Oligodendroglioma Cells

Documenti analoghi

• Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression
  di: Mercier, Marie Le, et al.
  Pubblicazione: (2009)
• Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
  di: Benjamin Le Calvé, et al.
  Pubblicazione: (2010-09-01)
• Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
  di: Le Calvé, Benjamin, et al.
  Pubblicazione: (2010)
• Temozolomide Modifies Caveolin-1 Expression in Experimental Malignant Gliomas In Vitro and In Vivo
  di: Bruyère, Céline, et al.
  Pubblicazione: (2011)
• Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
  di: Mathieu, Véronique, et al.
  Pubblicazione: (2008)